期刊文献+

彩色多普勒超声心动图在先天性心脏病合并肺动脉高压中的应用及分析 被引量:2

The Application and Analysis of Color Doppler Echocardiography in the Treatment of Cardiac Disease Complicated with PAH (Pulmonary Artery Hypertension)
下载PDF
导出
摘要 目的利用彩色多普勒超声心动图检测在先天性心脏病合并肺动脉高压中根据连续多普勒三尖瓣反流压差估测肺动脉收缩压的价值[1]。方法对60例左向右分流型先天性心脏病合并肺动脉高压,同时有三尖瓣反流的患者,于术前用上述方法估测肺动脉压/体循环压的比值,与术中所测得肺动脉压/体循环压的比值比较。结果多普勒超声心动图用上述方法估测肺动脉压/体循环压的比值,与术中所测得肺动脉压/体循环压的比值高度相关(r=0.82,P<0.01)。结论结果表明,多普勒超声心动图测压法可提供可靠的最大三尖瓣跨瓣压,可为患者临床药物治疗及病情分析提供宝贵的血流动力学资料,可用于肺动脉高压的定性和定量诊断,本方法可为外科提供手术时机,并对手术的可行性做出预测。 Objective To estimate the value of pulmonary arterial systolic pressure in terms of pressure difference in continuous-wave Doppler tricuspid regurgitation by using color doppler echocardiography in the treatment of inborn cardiac disease complicated with PAH (Pulmonary Artery Hypertension)cll. Methods 60 cases of left-to-right shunt inborn cardiac disease complicated with PAH and tricuspid regurgitation were taken as examples. The relative value of PAP/general circulation was estimated before the operation and then com- pared with PAP/general circulation during the operation. Results A high correlation ( r = 0. 82, P 〈 0. 01 ) could be observed to estimate the relative value of PAP/general circulation before and during the operation by color doppler echocardiography. Conclusions As the result indicates, color doppler echocardiography estimation can provide reliable maximum right atrioventricular valve straddle pressure, supplying valuable hemodynamics data to the clinic drug treatment and pathogenetic condition analysis. The application of it in lung artery hyper- baric qualitative and quantitative diagnose can provide surgery with the best juncture of operation and the predic- tion of the operation feasibility.
出处 《中国实用医药》 2010年第18期54-55,共2页 China Practical Medicine
关键词 先天性心脏病 肺动脉高压 多普勒超声心动图 Inborn Cardiac Disease PAH ( Pulmonary Artery Hypertension ) Doppler Echocardio- graphy
  • 相关文献

参考文献4

二级参考文献30

  • 1姜楞,沈学东.连续波多普勒测定肺动脉舒张压与平均压的研究[J].中华心血管病杂志,1989,17(1):3-6. 被引量:4
  • 2王国干,中华结核和呼吸杂志,1996年,19卷,290页 被引量:1
  • 3Rubin LJ,Badesch DB,Barst RJ,et al.Bosentan therapy for pulmonary arterial hypertension[J].N Engl J Med,2002,346:896-903. 被引量:1
  • 4Galiè N,Hinderliter AL,Torbicki A,et al.Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension[J].J Am Coll Cardiol,2003,41:1380-1386. 被引量:1
  • 5Barst RJ,Langleben D,Frost A,et al.Sitaxsentan,an ETA receptor antagonist,for the treatment of pulmonary arterial hypertension[J].Am J Respir Crit Care Med,2004,169:441-447. 被引量:1
  • 6Rimensberger PC,Spahr-Schopfer I,Berner M,et al.Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease:vasodilator capacity and cellular mechanisms[J].Circulation,2001,103(4):544-548. 被引量:1
  • 7Nagaya N,Uematsu M,Oya H,et al.Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension[J].Am J Respir Crit Care Med,2001,163:887-891. 被引量:1
  • 8Michelakis ED,Tymchak W,Noga M,et al.Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension[J].Circulation,2003,108:2066-2069. 被引量:1
  • 9Petkov V,Mosgoeller W,Ziesche R,et al.Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension[J].J Clin Invest,2003,111:1339-1346. 被引量:1
  • 10Marcos E,Adnot S,Pham MH,et al.Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension[J].Am J Respir Crit Care Med,2003,168:487-493. 被引量:1

共引文献44

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部